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Abstract
Background: In Nigeria, hepatitis B virus (HBV) infection has reached hyperendemic levels and its nature and origin have
been described as a puzzle. In this study, we investigated the molecular epidemiology and epidemic history of HBV
infection in two semi-isolated rural communities in North/Central Nigeria. It was expected that only a few, if any, HBV strains
could have been introduced and effectively transmitted among these residents, reflecting limited contacts of these
communities with the general population in the country.
Methods and Findings: Despite remoteness and isolation, ,11% of the entire population in these communities was HBV-
DNA seropositive. Analyses of the S-gene sequences obtained from 55 HBV-seropositive individuals showed the circulation
of 37 distinct HBV variants. These HBV isolates belong predominantly to genotype E (HBV/E) (n=53, 96.4%), with only 2
classified as sub-genotype A3 (HBV/A3). Phylogenetic analysis showed extensive intermixing between HBV/E variants
identified in these communities and different countries in Africa. Quasispecies analysis of 22 HBV/E strains using end-point
limiting-dilution real-time PCR, sequencing and median joining networks showed extensive intra-host heterogeneity and
inter-host variant sharing. To investigate events that resulted in such remarkable HBV/E diversity, HBV full-size genome
sequences were obtained from 47 HBV/E infected persons and P gene was subjected to Bayesian coalescent analysis. The
time to the most recent common ancestor (tMRCA) for these HBV/E variants was estimated to be year 1952 (95% highest
posterior density (95% HPD): 1927–1970). Using additional HBV/E sequences from other African countries, the tMRCA was
estimated to be year 1948 (95% HPD: 1924–1966), indicating that HBV/E in these remote communities has a similar time of
origin with multiple HBV/E variants broadly circulating in West/Central Africa. Phylogenetic analysis and statistical neutrality
tests suggested rapid HBV/E population expansion. Additionally, skyline plot analysis showed an increase in the size of the
HBV/E-infected population over the last ,30–40 years.
Conclusions: Our data suggest a massive introduction and relatively recent HBV/E expansion in the human population in
Africa. Collectively, these data show a significant shift in the HBV/E epidemic dynamics in Africa over the last century.
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Introduction
Hepatitis B virus (HBV) infection presents a global health
problem. Worldwide, at least 2 billion people or one third of the
world’s population have been infected with HBV. Approximately
378 million people are chronic carriers and ,620,000 people die
each year from acute and chronic sequelae of HBV infection [1,2].
Furthermore, 4.5 million new HBV infections occur worldwide
each year, of which a quarter progress to liver disease [3].
The HBV genome is a partially double-stranded circular DNA
molecule of ,3.2kb in length. It contains four partly overlapping
open reading frames (ORFs): the preS1/preS2/S ORF encoding
the hepatitis B surface antigen (HBsAg); the precore/core ORF
encoding the hepatitis B e antigen and core protein; the P ORF
encoding the polymerase protein; and the X ORF encoding the X
protein [4]. The HBV genome is heterogeneous and can be
classified into 8 genotypes: A, B, C, D, E, F, G and H. Currently,
HBV genotypes are defined based on at least 8% divergence
across the complete genome sequence [5] and less than 4% intra-
genotypic divergence [6].
HBV genotypes are known to be geographically segregated [7].
Genotype E (HBV/E) is predominant in the West/Central African
crescent spanning from Senegal to Angola [8,9,10]. Despite the
extensive spread of HBV/E in this crescent, the virus is marked by a
peculiarly low overall sequence diversity of 1.75% over the whole
genome [8]. It has been suggested that it would take 200 years to
generate the current extent of HBV/E diversity [11]. Rare findings of
HBV/E in the Americas suggest a relatively recent HBV/E
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HBV/E prevalence in Africa coupled with the high volume of the
Afro-American slave trade that took place between the 17
th and the
19
th century [8,11,12,13] would haveresulted in frequent detection of
HBV/E infection in the Americas. How HBV/E may have spread
within and throughout the HBV/E crescent remains a puzzle.
In Nigeria, HBV infection has reached hyperendemic levels
with the seroprevalence of HBsAg estimated to range from 10–
40% [13,14,15,16]. Despite the availability of a safe and effective
vaccine since 1982 [17,18] and its inclusion in Nigeria’s national
immunization program in 1995, the vaccine became available to
the country only in 2004 [19,20]. Owing to this late entry and the
absence of a national HBV surveillance program, the burden of
hepatitis B remains substantial.
The present study was conducted to obtain insight into the
molecular epidemiology of HBV/E in two remote rural commu-
nities in Nigeria, West Africa. These communities have limited
contact with the general population in the country. It was expected
that they were shielded from the major epidemiological processes
that introduced HBV infection in Nigeria. Sub-genomic and
whole-genome-based molecular epidemiological investigation
identified multifarious HBV/E strains in these communities.
Evolutionary analyses indicated the recent origin of the modern
HBV/E variants and suggested a massive introduction of HBV to
the communities at the same time it was introduced to the entire
West/Central Africa sub-region.
Materials and Methods
Serum samples and HBsAg serology
A total of 500 serum samples were collected from asymptomatic
volunteers residing in two neighboring remote rural communities in
Nasarawa State, Nigeria, West Africa in 2007. These two remote
communities are ,2 miles from each other with a total population of
,2000 inhabitants. The traditional heads of the communities served
as the society entry points. Written informed consent was obtained
from all participants involved in this study. The use of specimens in
this study was approved by the Institutional Review Board of the
Centers for Disease Control and Prevention, Atlanta, GA and the
Nigerian Federal ministry of Health. The inhabitants of these villages
are of low socio-economic status lacking basic medical facilities. The
commercially available Smart Check immunoassay (Globalemed,
Cape Town, South Africa) for the qualitative detection of HBsAg by
rapid chromatography was used for screening HBV infection in all
the samples and was conducted according to the manufacturer’s
instructions.
Nucleic acid extraction
Total nucleic acid was isolated from all serum samples (n=500)
using the robotic Roche MagNA Pure LC system (software version
3.0.11) and the MagNA Pure LC Total Nucleic acid isolation kit
(Roche, Applied Sciences, Indianapolis, IN) according to manu-
facturer’s instructions.
PCR amplification of the S gene
Amplification of the partial S-gene was performed in a nested
format to yield a product of approximately 400 bp using: for first-
round PCR primer pairs, HBV_S1F (position 179), 59-CGA TTT
AGG TGA CAC TAT AGA AGA GAG GCT CTA GGA CCC
CTG CTC GTG TT, and HBV_S1R (position 704), 59-CAG
TAA TAC GAC TCA CTA TAG GGA GAA GGC TCG AAC
CAC TGA ACA AAT GGC ACT; and for second-round PCR
primer pairs, HBV_SNF (position 217), 59-CGA TTT AGG TGA
CAC TAT AGA AGA GAG GCT GTT GAC AAG AAT CCT
CAC AAT ACC, and HBV_SNR (position 658), 59-CAG TAA
TAC GAC TCA CTA TAG GGA GAA GGC GGC TGA GGC
CCA CTC CCA TA. After a denaturation step at 95uC for
10 min, PCR reactions were performed in 30 cycles (95uC for
30 sec, 55uC for 1 min and 72uC for 32 sec) followed by melting
curve analysis (95uC for 1 min, 80uC for 30 sec and 95uC for
30 sec) performed in one cycle using an Mx3005P SYBR Green
Real-Time PCR System (Stratagene, La Jolla, CA).
HBV whole-genome amplification
Full-length HBV genome was amplified by two rounds of PCR.
The first round of PCR was conducted using the primer
combination of HBV1798FLong and HBV1801RLong (Table 1)
as follows: initial denaturation (94uC for 3 min), followed by 10
cycles with each cycle consisting of denaturation at 94uC for 20 sec,
annealing at 55uC 245uC for 30 sec, and extension at 68uC for
4 min. Annealing temperature was reduced at the rate of 1uC per
cycle from 55uCt o4 5 uC. Thereafter followed 35 cycles, with each
cycle consisting of denaturation at 94uC for 20 sec, annealing at
45uC for 30 sec and extension at 68uC for 4 min. The extension
time was increased by 10 sec/cycle up to 7.2 min. The final
extension was at 68uC for 10 min followed by cooling at 4uC. The
first-round PCR was performed on the GeneAmpH PCR system
9700 (Applied Biosystem) using the Expand High-Fidelity PCR test
kit. The nested PCR was done with setof six overlapping fragments,
using the following primer combinations (Table 1): (HBV1847FS
with HBV2394RS, HBV2298FS with HBV2933RS, HBV2821FS
with HBV0272RS, HBV0179FS with HBV0704RS, HBV0599FS
with HBV1286RS and HBV1175FS with HBV1788RS) under the
followingcycling conditions: pre-incubationat 95uC for5 min, after
which amplification for 25 cycles, each cycle consisting of
denaturation at 95uC for 15 sec, annealing at 55uC for 20 sec
and extension at 72uC for 1 min. After amplification, melting curve
analysis was performed by raising the temperature to 95uC
for 0.01 sec in one cycle using the Mx3005P SYBR Green Real-
Time PCR System (Stratagene, La Jolla, CA). The derivative
melting curves were obtained with the instrument data analysis
software.
S-gene quasispecies analysis
Twenty-two HBV/E samples representing the major branches of
the HBV/E phylogenetic tree and the two HBV/A3 samples were
used for quasispecies analysis. Five specimens in this HBV/E panel
wereobtained from2 groups of siblings. Additionally, whenselecting
samples for quasispecies analysis, preference was given to genetically
close HBV/E variants identified in each major branch of the
phylogenetic tree in order to assess potential transmissions. This
subset was analyzed using an adaptation of our previous method,
end-point limiting-dilution real-time PCR (EPLD-PCR) to HBV
[21] that could detect HBV S-gene variants at a concentration of
0.1% of the total viral population [22]. Briefly, EPLD-PCR was
performed using serially diluted DNA. The BiomekH 3000 robotic
work station (Beckman Coulter, Brea, CA) was used to obtain 0.25
log dilutions of the HBV DNA. The dilution that resulted in
positivity in two of four replicates was considered to be limiting
(DNA target templates being assumed to be distributed in a Poisson
manner so that 50% or less reactions do not carry template
molecules and thus do not generate PCR products). Under such
conditions, the positive reactions are most likely to have been
initiated from a single template molecule. The LightCyclerH 480
software (Version 1.5.0.SP3, Roche, Indianapolis, IN,) was used to
perform the melting curve analysis. For each isolate, 96 EPLD
amplification reactions were carried out to obtain approximately 48
clones per sample; the exact number varied depending on the viral
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Gaithersburg, MD) was used for the PCR amplification.
DNA sequencing
Sequencing was performed using the second-round PCR
products. SP6 and T7 primers (Table 1) were used for sequencing
of the PCR products using BigDye version 3.1 in an automated
DNA sequencer ABI 3130xl (Applied Biosystems, Foster City,
CA). Sequencing PCR involved 25 cycles, each cycle consisting of
96uC for 10 sec, 50uC for 5 sec and 60uC for 4 min. Sequence
electrophoregrams were initially analyzed and edited using the
SeqMan and MegAlign programs of the Lasergene DNA and
protein software version 7.0 (DNASTAR Inc., Madison, WI).
Phylogenetic analysis and inference of serotypes
Nucleotide sequences were aligned using the GCG (Version
11.1.2-UNIX, Accelrys Software Inc, San Diego, CA) multiple
alignment program Pileup. HBV genotypes were classified based
on the S-gene sequence and confirmed with whole-genome
sequences by comparing each sequence with published reference
sequences from GenBank. Initial Neighbor-joining trees were built
using the Kimura two-parameter model of nucleotide substitution
[23]. Phylogenetic trees were constructed using the maximum
likelihood algorithm implemented in Dnaml (PHYLIP package,
v.3.6). Frequency distributions of pair-wise distances between
nucleotide sequences were estimated using the evolution program
in the Accelrys GCG Package (Genetic Computer Group, version
11.1-UNIX, Accelrys Inc., San Deigo, CA). SAS for Windows
(Version 9.12, SAS Institute Inc., Cary, NC) was used for statistical
analysis. HBV serotypes were predicted based on amino acid
sequences at positions 122, 160, 127 and 134 in the S gene [24,25].
Median-Joining network (MJN)
MJN of the S-gene quasispecies of HBV/E and HBV/A3 were
constructed using the program NETWORK 4.0 [26]. The MJN
method begins computing the minimum spanning trees (a graph that
connects all the sequences with the minimum necessary total length of
the branches), following which all the constructed graphs are combined
within a single (reticulate) network. Aiming at parsimony, the algorithm
subsequently adds a few consensus sequences (called Median Vectors)
of three mutually close sequences at a time. These median vectors can
be biologically interpreted as possibly extant but unsampled sequences
or extinct ancestral sequences. The resulting network normally harbors
all optimal trees, as well as numerous suboptimal trees [26].
Genetic structure of HBV/E
Every complete genome of HBV was obtained from the National
Center for Biotechnology Information Website (NCBI) in late 2008.
All sequences were aligned using ClustalW [27]. Further refinement
of the alignment was made manually. Two tests for detecting
population growth based on the Tajima’s D [28] and Fu’s FS [29]
statistics were performed using ARLEQUIN [30]. A p value of 0.05
or less was considered statistically significant.
Geographic distribution
Nucleotide sequences identical to the most frequent S- gene
sequence variant found in this study were selected from GenBank
using BLAST [31]. Information on the geographic location where
these sequences were identified was extracted from GenBank and
published articles.
Prediction of the Most Recent Common Ancestor (MRCA)
MRCA of the S gene was determined using FASTML version
2.02 [32] from the basal node on a maximum-likelihood tree of
nucleotide sequences deduced from the S-gene quasispecies of 22
HBV/E variants, using as out-group a sequence from a patient
infected by a different genotype.
Divergence time calculations of HBV genotype E
Divergence times were calculated using 47 P gene sequences of
HBV/E from the two Nigerian villages. A second sequence
Table 1. PCR primers.
Primer name Primer sequence
HBV1798FLong CTGCGCACCAGCACCATGCAACTTTTTC
HBV1801RLong CAGACCAATTTATGCCTACAGCCTCCTA
HBV1847FS CGATTTAGGTGACACTATAGAAGAGAGGCTTGTTCATGTCCCACTGTTCAA
HBV2394RS CAGTAATACGACTCACTATAGGGAGAAGGCTGGCGAGGGAGTTCTT
HBV2298FS CGATTTAGGTGACACTATAGAAGAGAGGCTGACCACCAAATGCCCCTAT
HBV2933RS CAGTAATACGACTCACTATAGGGAGAAGGCTTCGGGAAAGAATCCCAGAGGAT
HBV2821FS CGATTTAGGTGACACTATAGAAGAGAGGCTGGTCACCATATTCTTGGGAAC
HBV0272RS CAGTAATACGACTCACTATAGGGAGAAGGCTTGAGAGAAGTCCACCACGAGT
HBV0179FS CGATTTAGGTGACACTATAGAAGAGAGGCTCTAGGACCCCTGCTCGTGTT
HBV0704RS CAGTAATACGACTCACTATAGGGAGAAGGCTCGAACCACTGAACAAATGGCACT
HBV0599FS CGATTTAGGTGACACTATAGAAGAGAGGCTGTATTCCCATCCCATCATCCTG
HBV1286RS CAGTAATACGACTCACTATAGGGAGAAGGCTGCTAGGAGTTCCGCAGTATGG
HBV1175FS CGATTTAGGTGACACTATAGAAGAGAGGCTGCCAAGTGTTTGCTGA
HBV1788RS CAGTAATACGACTCACTATAGGGAGAAGGCTGCCTACAGCCTCCTA
SP6 cgatttaggtgacactatagaagagaggct
T7 cagtaatacgactcactatagggagaaggct
*Numbers within primer names represent the primer positions. An F after the primer position stands for sense primers while R stands for anti-sense primers.
**SP6 and T7 are tag sequences attached at the 59 end of all PCR primers used in this study. SP6 and T7 primers were used to sequence PCR fragments.
doi:10.1371/journal.pone.0011615.t001
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with known dates of collection to the original Nigerian sequences.
The accession numbers for these sequences are (AB194947),
(AB194948), (AB205129), (AB205189), (AB205190), (AB205191),
(AB205192), (AP007262), (AY738144), (AY738145), (AY738146)
and (AY738147). Divergence times were calculated using BEAST
v 1.4.8 [33]. The GTR substitution model was used with four
gamma categories and invariant sites. Codons were partitioned
into three with unlinked substitution model and unlinked rate
heterogeneity model across the codon partitions. Each sequence
alignment was analyzed with a strict or relaxed clock with an
initial estimate for the rate of substitution as 2.97610
24 [34].
Constant size, exponential and expansion growth priors were used.
All models were run until the effective sample size for each was
greater than 200. In order to compare the models, the Bayes
Factor was estimated using importance sampling of the posterior
probability [35]. The exponential substitution model with an
expansion growth prior was chosen because it had the largest
Bayes Factor; however, none of the models tested was found to be
superior to any other model. Only HBV/E isolates were included
in the BEAST analysis.
The effective population of the Nigerian HBV sequences was
calculated using the skyline plot as implemented in BEAST. All
models tested showed an expansion in the effective population of
HBV in these two villages. The Bayes Factor for these models
indicated that no single model was superior to any other model.
The plot chosen for presentation here was the strict clock with the
piecewise linear Bayesian skyline model with three population
groups.
Detection of positive selection
To determine if the HBV/E strains that are uniquely restricted
to the HBV/E crescent are adapted to the populations in that
region, we calculated overall and site-by-site selection pressures
acting on the four ORFs in the 47-HBV/E whole genomes. We
estimated the mean numbers of non-synonymous substitutions (dN)
and synonymous substitutions (dS) per site (ratio dN/dS) using the
Fixed Effects Likelihood (FEL) analysis implemented in the
program HyPhy 0.99 beta [36], which is available in a parallel
computing fashion at the Datamonkey web interface [37]. The
algorithm works in three phases [38,39]: first, the General Time
Reversible nucleotide model was fitted to the data and tree using
maximum likelihood to obtain branch lengths and substitution
rates; second, a codon model was fitted to the data to obtain codon
branch lengths for scaling dN and dS estimated subsequently from
each site; and thirdly, a site-by-site likelihood-ratio test was
performed to assess whether dN is significantly different from dS.
Nucleotide sequence accession numbers
The S-gene sequences of the 55 HBV isolates have been
deposited in the National Center for Biotechnology Information
GenBank database under the accession numbers (HM363565) to
(HM363619). The 47 HBV/E and the two HBV/A3 full-genome
sequences were deposited with accession numbers (HM363565) to
(HM363611) and (HM363612) to (HM363613) respectively.
Results
HBV seroprevalence
The 500 samples collected from the 2 villages were tested for
HBsAg and for HBV DNA by the S-gene PCR. Fifty-three
samples were HBsAg-positive and 55 were HBV-DNA-positive.
All HBsAg-positive specimens were found to be HBV DNA-
positive. However, HBsAg was not detected in 2 HBV DNA-
positive specimens. In all, 55 samples were HBV-positive giving an
overall prevalence of 11%, indicating a high prevalence of HBV
infection.
Phylogenetic analysis of HBV variants
Taking into consideration the relative isolation of these 2
communities, it can be expected that only a single HBV strain or
very few strains are in circulation in their populations. However,
analysis of the S-gene sequences identified 2 HBV genotypes, A
(sub-genotype A3, n=2) and E (n=53), with 2 and 35 distinct
sequence variants representing HBV sub-genotype A3 and
genotype E, respectively (Fig. 1). To further characterize these
HBV variants, the full-length HBV-genome sequences from 47
HBV/E-infected individuals and 2 HBV/A3-infected individuals
were obtained. Six HBV/E isolates did not yield a complete
sequence probably due to low viral titers. Phylogenetic analysis of
the full genomes for 47 HBV/E and two A3 isolates confirmed the
genotype classification based on the S-gene sequences (Fig. 2) and
further substantiated that a wide diversity of HBV strains
circulated in both communities. Consistent with analysis of the
S-gene sequences, phylogenetic analysis of the whole-genome
sequences (Fig. 2) did not reveal any village-specific clustering and
showed extensive intermixing of these sequences with other HBV/
E variants identified in different countries in Africa.
Serotype distribution of HBV strains
Based on the presence of Arg
122, Lys
160 and Leu
127/Ile
127
[24,25] all the A3 isolates could be classified as serotype ayw1.
Among the 53 HBV/E isolates, two isolates could be classified as
serotype ayw2 (3.7%). All the others belonged to ayw4 (96.3%).
The ayw2 was deduced by the presence of Pro
127 and Phe
134
[24,25].
Intra-host HBV heterogeneity
The presence of 2 HBV genotypes and many HBV strains raises
questions about the origin and maintenance of this remarkable
HBV diversity in these two communities. To investigate the extent
of variant/strain distribution and their spread within the
population, quasispecies analysis was conducted using EPLD
RT-PCR [21] on 2 HBV/A3 and 22 HBV/E specimens. The
quasispecies analysis revealed many HBV/E variants (n=229)
circulating in these 2 communities and substantial intra-host
diversity in all individuals (Fig. 3). Among individuals infected with
HBV/E, 3 were co-infected with HBV genotype G and 2 with
HBV genotype D (Fig. 4). Genetic diversity between HBV variants
identified in 19 individuals infected with only one HBV genotype
was in the range of 0.8%–3.6%, while individuals coinfected with
two genotypes (HBV/G and HBV/D) showed higher variability
ranging from 5.4%–7.1% (Table 2). The HBV sequence variants
identified in the 2 individuals infected with genotype A3 strains
were separated into 2 clusters in the phylogenetic tree (Fig. 1 and
2), indicating that both individuals were infected with 2
independent strains. Initial phylogenetic analysis showed strong
intermixing of the HBV/E variants recovered from different
residents (not shown). To visualize genetic interconnections
between HBV variants and show variant frequencies in the
population at the same time, we used a MJN [26]. Among 229
HBV variants, 210 (91.7%) were unique and 19 (8.3%) were found
in more than one individual. The most frequent HBV sequence
was shared by 10 residents of both villages; it was located in the
center of the MJN and had the highest number of direct links to
other sequences (Fig. 3). The majority of the high-frequency HBV
variants were located in proximity to the center of the MJN.
Among 19 HBV variants shared by more than one individual, 8
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MJN (Fig. 3). These findings indicate a very close genetic
relatedness between predominant and frequently shared HBV/E
variants.
Network of shared HBV sequences
Interestingly, among the 22 HBV/E infected people only 2 were
infected with unique strains, while the other 20 individuals were
infected with at least one HBV variant shared by two or more
residents. The quasispecies analysis identified 19 different
sequences distributed among 20 HBV/E infected individuals,
with each person sharing HBV sequences with 2 to 14 other
people (Fig. 3). A network of shared HBV sequences was
constructed (Fig. 5) using the distribution of HBV/E sequences
among infected people. In this network, each node represents a
person infected with the HBV/E strain and each link connects
individuals sharing at least one HBV/E sequence. The network is
very densely connected. Ten individuals, a67, a84, a85, a112,
a227, c16, c19, c98, v67 and v137, representing a half of all nodes
in the network, are completely interlinked, thus constituting the
largest complete clique or the entirely interlinked component of
the network.
The network and the largest clique included males and females
of different ages residing in both villages (Fig. 5). Such extensive
HBV strain sharing suggests very efficient HBV transmission
between residents of both villages. This transmission seemed
effective among both genders and people of a wide range of ages.
Among 24 individuals tested for HBV quasispecies, 5 were females
with the age ranged from 5 to 21 yr and 19 were males between 15
and 66 yr. All 5 females were infected with HBV/E strains shared
with other persons. The linked females resided in both villages.
Among 20 linked individuals, two were males, 60 and 66 yr old;
both resided in the same village.
Among 24 individuals tested for HBV quasispecies, we
identified two groups of siblings residing in the same village.
Siblings a84 and a85 were found sharing HBV variants not only
with each other but also with 13 and 9 other individuals,
respectively (Fig. 5). Both were members of the largest clique in the
HBV/E network. However siblings v5, v64 and v157 did not share
any HBV/E variants with each other. Sibling v157 was not
connected to the network. Siblings v5 and v64 were part of the
network but did not have a direct link between each other and
shared HBV/E variants only with 2 other individuals residing in
the same village (Fig. 5). These observations suggest that HBV
transmission between siblings was not the major route of
transmission in these communities. Involvement of individuals
with a wide range of demographic characteristics in the network of
shared HBV/E sequences implies a complex pattern of transmis-
sion operating among residents of these 2 villages. This supposition
is consistent with finding four HBV genotypes and numerous HBV
variants circulating in the 2 communities. Interestingly, the
quasispecies analysis of both HBV/A3 strains showed no
coinfection with any other HBV strain found in this population
(Fig. 6) despite a significant HBV prevalence and frequent
coinfections between HBV/E strains.
Selection pressures
Continuous circulation of HBV strains in closed communities
may lead to the unique HBV adaptation under selection pressures
acting specifically on their populations. Such selection pressures
may be detected by determining dN/dS ratios. Analysis of the dN/
dS values for each of the four ORFs of the 47 HBV/E isolates
showed that the evolution of these HBV variants was driven
predominantly by negative or purifying selection. Specifically, the
mean dN/dS for the P, precore/core, X and S genes were 0.390805
(95% CI, 0.3538–0.430356), 0.631286 (95% CI, 0.553566–
0.715977), 0.880608 (95% CI, 0.745113–1.03199), and
0.638155 (95% CI, 0.537437–0.750901), respectively. However,
five codons of the P gene, four codons of the precore/core gene,
three codons of the X gene and one codon of the S gene showed
statistically significant evidence of positive selection (Table 3).
A substitution within codon 762 of the P gene showed a
statistically significant evidence of positive selection (p=0.044). A
non-synonymous substitution affected codon 768. These two
codons encode amino acids at the anchor positions 2 and 8 within
a potential HLA A23, HBV T-cell epitope [40], which is one of
the most frequent HLA alleles in Nigeria and the West/Central
Africa sub-region [16,41,42]. Although analysis of the HBV
genotype A, C and D sequences retrieved from GenBank
identified mutations within the same T-cell epitope, none of these
mutations affected the anchor positions (data not shown). This
finding suggests the HBV/E-specific adaptation to HLA-restricted
immunological responses. The significance of the other sites under
positive selection within the HBV/E genome is unclear.
Geographic distribution of the most frequent HBV/E
variant
The most frequent HBV/E sequence variant located in the
center of the MJN (Fig. 3) was found to be identical to the HBV/E
MRCA. A search of GenBank using BLAST yielded 160
nucleotide sequences identical to the HBV/E MRCA, 130 of
which had associated information on their geographic location in
Africa. These sequences were broadly distributed across West
Africa (Benin, n=2; Burkina Faso, n=1; Gambia, n=30; Ghana,
n=28; Guinea, n=41; Mali, n=3; Nigeria, n=10; Togo, n=2),
Central Africa (Central African Republic, n=1; Cameroon,
n=11) and Madagascar (n=1).
Time to the most recent common ancestor of HBV/E
The remote location of these 2 Nigerian villages suggests
infrequent opportunities for HBV to be introduced to these
communities. However, the identification of 4 HBV genotypes and
numerous HBV/E variants implies more than one introduction of
HBV. In order to evaluate the epidemic history of HBV/E in the
villages we calculated the tMRCA for the HBV isolates identified
in this study. A number of models were used which showed that
the tMRCA for the HBV/E variants found in these communities
existed ,60 years ago (1952; 95% HPD: 1927–1970). However, it
should be noted that analysis of sequences linked to a single date of
collection could result in underestimating the true tMRCA. To
place the tMRCA for these HBV/E isolates within the time frame
for the entire HBV genotype E, the tMRCA was calculated for all
HBV/E variants found in different countries of West/Central
Africa in addition to those identified in this study. This calculation
showed that the tMRCA for the entire HBV/E also existed ,60
years ago (1948; HPD: 1924–1966). These results suggest that the
HBV/E variants from the 2 communities originated at the same
time as HBV/E strains circulating in the entire HBV/E crescent.
Figure 1. Phylogenetic tree of the partial S-gene sequences (378bp) from 55 Nigerian HBV isolates identified in this study (marked N)
and sequences recovered from GenBank (not marked). Sequences retrieved from GenBank are denoted by their accession numbers and the
source country of the isolates. Bootstrap values of major branches are shown.
doi:10.1371/journal.pone.0011615.g001
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The recent origin and broad distribution of the HBV/E variants
in West/Central Africa suggests a rapid population expansion of
HBV/E infections. Indeed, both Tajima’s D and Fu’s FS tests
rejected the null hypothesis of neutrality and constant population
size (p=0.0046 and 0.0009, respectively), suggesting the expan-
sion of the HBV/E population. The star-like topology of the MJN
constructed for the HBV/E quasispecies (Fig. 3) is consistent with
this suggestion. Skyline plot analysis (Fig. 7) of HBV/E variants
found in these 2 communities supported these observations and
showed an increase in the effective number of HBV/E infections
over time. Collectively, these findings indicate significant changes
in the epidemiological processes affecting HBV/E infection over
the last 50–100 years.
Discussion
Analysis of serum specimens collected from two remote rural
communities in North Central Nigeria revealed that ,11% of
their residents were actively infected with HBV. Although this
high prevalence concurs with the rate of HBV infection of 10–40%
found in other populations across Nigeria [13,14,15,16], it is
surprising that limited outside contacts did not shield these
communities from HBV infection. Taking into consideration the
isolation of these communities from the general population and
the high prevalence of HBV infection, it is conceivable that only a
few HBV strains could have been introduced and effectively
transmitted among the residents. However, phylogenetic analysis
of the S-gene sequences from 55 HBV isolates recovered in this
study showed the presence of many HBV variants that belong to
two genotypes, A and E (Fig. 1 and 2).
HBV/E was the most prevalent genotype, being detected
among 96.4% of the isolates. Phylogenetic analysis showed that all
the HBV/E variants were closely related to HBV/E strains
circulating in West and Central Africa (Fig. 1 and 2). Detection of
the most frequent HBV/E variant (Fig. 3) in many African
countries strongly supports close genetic relatedness between
HBV/E variants in these communities and other regions of Africa.
These findings are in agreement with the previous observation of
HBV/E in the majority of HBV-infected individuals in Nigeria
[13]. Additionally, it confirms that Nigeria is part of the HBV/E
crescent spanning countries from Senegal to Namibia
[8,11,13,43]. Only 2 (3.6%) isolates belonged to HBV/A3, and
both preferentially clustered with the recently identified HBV/A3
isolates from Cameroon [44] rather than with HBV/A3 isolates
from Gabon [45]. Cameroon could have been a possible source of
HBV/A3 into Nigeria owing to the substantial volume of trade
and intermarriage between these two neighboring countries (J.C.F.
Figure 2. Phylogenetic tree of the 47 HBV/E and 2-HBV/A3 whole genome sequences from Nigeria (markedN) and GenBank
references (not marked). Sequences retrieved from GenBank are denoted by their accession numbers and the source country of the isolates.
Bootstrap values of major branches are shown.
doi:10.1371/journal.pone.0011615.g002
Figure 3. Median joining network of the intra-host S-gene sequence variants identified in 22 individuals infected with HBV/E. Each
node represents a single sequence variant. Each color represents a single individual. The size of the node reflects frequency of the corresponding
variant in the population.
doi:10.1371/journal.pone.0011615.g003
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with the African/Asian A1 or European/American A2 subgeno-
types.
Of the 53 HBV/E isolates, 51 (96.2%) were predicted to belong
to serotype ayw4 and 2 (3.8%) to ayw2, while the 2 HBV/A3
isolates belonged to ayw1. These data are in disagreement with
previous findings that all HBV/E from Africa belonged to serotype
ayw4 [13,46,47]. No evidence of recombination was found in the
HBV/E ayw2 isolates. The geographical distribution and frequen-
cy of HBV/E ayw2 are not known.
Phylogenetic analysis of the whole-genome sequences (Fig. 2)
did not reveal any village-specific clustering and showed extensive
intermixing of these sequences with other HBV/E variants
identified in different countries in Africa. Genetic diversity
between the whole-genome sequences identified for HBV/E
isolates circulating in the 2 communities was 2.1%, which is
similar to the range found among all other HBV/E variants
[8,11,43]. Such low genetic diversity among these local HBV/E
isolates indicates that the virus might have only been recently
introduced into these rural populations. Additionally, the presence
of many HBV/E variants in the 2 communities and apparent
intermixing with variants from other African countries suggest that
all these HBV variants were introduced rather than having
independently evolved in these communities. Because of limited
Figure4. Phylogenetic tree of HBV sequence variants identified in 5 individuals with mixed genotype infections. Sequences identified in
this study are colored. Reference sequences retrieved from GenBank for genotypes HBV/E, HBV/G and HBV/D are shown in black. The consensus
S-gene sequences for each individual are indicated with white arrows. All sequences that obtained from a single individual are shown using same color.
doi:10.1371/journal.pone.0011615.g004
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for extraneous transmission, and, therefore, these HBV variants
were most probably introduced to these villages simultaneously or
within a very short timespan.
Analysis of HBV quasispecies from 24 residents of these 2
communities revealed that each individual was infected with
many different HBV variants (Fig. 3). Identification of the
genotype D and G sequences in 5 individuals (Fig. 4) adds
another level of complexity to HBV populations circulating in the
2 communities. However, the consensus sequences identified by
direct sequencing of PCR fragments (Fig. 1 and 2) did not
accurately reflect the genotype complexity of the HBV popula-
tion in each infected person. Among 22 residents infected with
HBV/E, 20 shared HBV variants with 2–14 other individuals.
Variant sharing was so extensive that a large network of shared
HBV sequences linking 20 residents could be constructed (Fig. 5).
Among these 20 residents, 10 were completely interlinked
through shared HBV sequences to each other. Should variant
sharing be considered as the proof of transmission [48,49], this
network reveals a very complex pattern of HBV transmission,
which could be related to frequent infections with more than one
HBV variant or to extensive superinfections with different HBV
variants. The network contains male and female individuals of
different ages residing in both villages, which suggests that HBV
transmission occurred across both communities via a mode
affecting the entire population.
The predominant mode of transmission leading to such
significant HBV variant sharing is not known. Analysis of HBV
quasispecies shared within 2 groups of siblings suggests that intra-
familial transmission is not the only possible mode of transmission.
These numerous HBV strains could have been maintained within
the population through socio-cultural practices like facial or body
scarification, traditional birth attendance and shaving by local
barbers using unsterilized sharp instruments, all of which have the
potential for the transmission of blood-borne pathogens and which
have been associated with the transmission of human immunode-
ficiency virus (HIV) in Nigeria [50,51].
Phylogenetic analysis also indicated a very close genetic
relatedness between predominant and frequently shared HBV/E
variants. These observations in conjunction with the star-like
MJN topology suggest a very dynamic evolution of HBV/E
variants found in these communities. The close connections
between the HBV/E variants (Fig. 3 and 5) and frequent sharing
of HBV sequences between individuals did not allow for a clear
division of these HBV/E variants into separate strains,
suggesting that the population of variants can be seen as a
single swarm evolving among many hosts. Given the significant
intermixing between the HBV/E variants found in this study and
HBV/E variants identified in other African countries, together
with the low heterogeneity of all these variants, this suggestion
seems applicable to the entire HBV/E. The existence of this
swarm of closely related HBV variants may reflect its recent
Table 2. Divergence within the HBV S-gene quasispecies.
Isolates
Age
(years) Gender Community
HBV
genotype
HBV
Serotype
Number
of Clones
Number of
unique clones
% Divergence within
quasispecies
Co-infecting
HBV genotype
A32 30 M 1 E ayw4 96 3 0.8 -
A51 66 M 1 E ayw4 46 19 1.8 -
A58 33 M 1 E ayw4 40 17 2.5 -
A67 60 M 1 E ayw4 15 4 0.8 -
A84 30 M 1 E ayw4 77 24 3.8 -
A85 15 M 1 E ayw4 64 15 1.8 -
A100 19 M 1 E ayw4 65 3 1.3 -
A112 21 F 1 E ayw4 88 11 1 -
A178 5 F 1 E ayw4 48 12 2.3 -
A227 18 M 1 E ayw4 86 17 7.1 (2.8) D
C16 24 M 2 E ayw4 23 7 1.0 -
C19 25 M 2 E ayw4 66 19 1.8 -
C8 25 M 2 E ayw4 46 14 6.8 (1.8) D
C98 12 F 2 E ayw4 59 10 1.5 -
V5 23 M 1 E ayw4 8 6 5.4 (2.0) G
V16 21 F 1 E ayw4 96 13 1.0 -
V30 22 M 1 E ayw4 92 37 6.0 (0.8) G
V64 27 M 1 E ayw4 41 12 1.3 -
V67 19 F 1 E ayw4 15 7 6.8 (1.5) G
V100 26 M 1 E ayw4 44 11 1.8 -
V137 20 M 1 E ayw4 47 8 0.8 -
V157 24 M 1 E ayw4 18 12 2.5 -
V103 22 M 1 A ayw1 78 4 2 -
C3 24 M 2 A Ayw1 45 12 2.5 -
*The percentage diversity in bracket represents the genetic distance observed when co- infecting viral genotypes was removed from the analysis. Gender: M=male,
F=female. Location: Village 1 and village 2.
doi:10.1371/journal.pone.0011615.t002
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particular transmission mode in the West/Central African
HBV/E crescent.
The origin of HBV/E remains unclear. The very rare detection
of HBV/E infections outside of Africa suggests that HBV/E
became prevalent in the West/Central Africa only after the trans-
Atlantic slave trade [8,9,10,11,12,13,43,52]. This hypothesis of the
recent HBV/E origin was supported by tMRCA analysis. The
MRCA for the 47 HBV/E full-length isolates identified in this
study was estimated to appear in ,1952 (95% HPD: 1927–1970).
Surprisingly, a similar tMRCA (,1948; 95% HPD: 1924–1966)
was estimated for the entire HBV/E. These findings indicate that
the HBV/E variants identified in the 2 villages and in the entire
HBV/E crescent in Africa have a similar time of origin.
Uncertainty in establishing the rate of substitutions for HBV may
significantly affect estimates of tMRCA. Recently, tMRCA for HBV/
E has been estimated to range between 30 to 1536 years depending on
the used substitution rate [53]. The rate of 2.97610
24 substitutions
per site per year [34] used in the present analysis is most consistent
with estimates made in several studies [54]. The analysis conducted
here dated the HBV/E MRCA within a timeframe consistent with the
hypothesis that modern HBV/E lineages emerged after the cessation
of the trans-Atlantic slave trade [8,11,12,13].
Although the modern HBV/E variants have a recent origin, the
HBV/E variants were probably present long before the calculated
tMRCA. Therefore, HBV/E could still have been introduced to
the other parts of the world through the slave trade. The recent
discovery of HBV/E variants among individuals of African
descent in one isolated community in Colombia, South America
[53] provides some support to this hypothesis. The coalescent
analysis conducted in that study suggested that the closely related
HBV/E variants found in that community originated from a single
variant that existed a few years ago, thus indicating that only a
single HBV/E strain was introduced to that community [53].
Considering its isolation and lack of contacts with persons
traveling from Africa over the period of time exceeding the
calculated tMRCA for these variants [53], it can be speculated
that the ancestral HBV/E strain was introduced to that
community many years ago, possibly even during the time of
the slave trade.
Figure 5. Network of individuals sharing identical sequences. Each node represents an individual and the link connects individuals that share
at least one HBV variant. Blue nodes belong to village 1 (light for females, dark for males) and yellow nodes belong to village 2 (light for females, dark
for males).
doi:10.1371/journal.pone.0011615.g005
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infected with and maintained a diverse population of HBV/E
variants. This diversity is of the same degree as for all HBV/E isolates
identified in different countries of Africa. Thus, HBV/E variants
from Colombia [53] and the 2 communities in this study most
probably had different evolutionary and epidemiological histories.
Although the actual epidemiological and evolutionary processes
leading to such a difference in the HBV/E sequence diversity are not
known, it may be speculated that the conditions for massive
introduction of multifarious HBV variants to the Nigerian commu-
nities did not exist when HBV was introduced to the Colombian
community.
Strikingly, the estimated divergence dates for the identified
HBV/E variants from the MRCA coincide with the period of
intense mass public-health campaigns conducted in West/Central
Africa. During 1967–1969, the World Health Organization
mounted a large-scale program to eradicate smallpox and measles
in West and Central Africa by arm-to-arm injections using jet
injectors that have been recognized as presenting a significant risk
for infection by blood-borne pathogens [55,56,57]. The geograph-
ical area stretching from Mauritania to the Congo (Zaire) river and
from the Bight of Benin to the Sahara desert, covering 20
countries, constituted a single contiguous territory with ,120
million inhabitants at that time. Between January 1967 and
December 1969, one hundred million persons living in this belt
were vaccinated against smallpox [57]. However, the mass
vaccination practices were already adopted more than 50 years
before the campaigns began. Mass inoculations against smallpox
was carried out in the late 19
th century in Nigeria, Benin, Ghana,
Guinea and Burkina-Faso that involved serial exchanges of blood
and lymph [58,59,60,61]. These could have constituted a route
along which HBV/E was transmitted. It has been proposed that
mass vaccination campaigns were associated with the dissemina-
tion of HBV/E in this region of Africa [55,62]. In Egypt, unsafe
injections used during nationwide campaigns against schistosomi-
asis between 1920 and 1980 have been associated with the
country’s high prevalence (.40%) of hepatitis C virus (HCV)
infection [63,64]. With HBV estimated to be ,10 times more
transmissible than HCV [62,65], unsafe injections are a possible
route of HBV/E transmission.
The data obtained in this study, although providing no direct
indication on the actual events leading to the high HBV
Figure 6. Median joining network of the intra-host S-gene
sequence variants identified in 2 individuals infected with
HBV/A3. Each node represents a single sequence variant. Each color
represents a single individual. The size of the node reflects frequency of
the corresponding variant in the population.
doi:10.1371/journal.pone.0011615.g006
Table 3. The number of negatively selected sites and specific sites under positive selection.
ORFs Number of negatively selected sites Positively selected sites P-Value for positively selected sites
Polymerase 66 Codon 11 0.010608
Codon 295 0.024116
Codon 681 0.011953
Codon 762 0.044131
Codon 827 0.041043
PreC/Core 17 Codon 20 0.045301
Codon 29 0.017184
Codon 87 0.033245
Codon 103 0.011595
X 8 Codon 76 0.036484
Codon 127 0.006012
Codon 129 0.028060
S 12 Codon 170 0.033047
doi:10.1371/journal.pone.0011615.t003
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transmission that resulted in rapid expansion of the HBV/E-
infected population. In addition to the Bayesian coalescent,
phylogenetic and MJN analyses described above, the Tajima’s D
and Fu’s statistical tests [28,29] provided support to this
hypothesis. Analysis of the skyline plot (Fig. 7) for HBV/E
variants identified in these 2 communities showed increase in the
effective number of HBV/E infections ,30–40 years ago.
Identification of HBV/E variants identical in the S-gene
sequence to the HBV/E MRCA in many countries in Africa
also suggests a rapid HBV/E spread. The conditions facilitating
such massive HBV/E expansion are not known. It is possible that
HBV/E was the most prevalent genotype in this region of Africa
before the expansion and/or the most adapted to the mode of
transmission leading to such expansion. Analysis of selection
pressures acting in the 2 Nigerian communities identified only
few HBV/E sites under the positive selection (Table 3).
Identification of a unique positively selected site at the anchor
position of the potential T-cell epitope in the polymerase
[40,41,42] supports a possible unique adaptation of HBV/E at
the population level. All these findings suggest a dramatic shift in
the epidemiological factors and evolutionary trends affecting the
presentation of HBV/E in the West and Central Africa sub-
region over the last century.
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